Shandong Polymer Biochemicals Co., Ltd. carries a market capitalization of 3.26B, placing it among publicly traded companies globally. Its enterprise value stands at 2.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.26B |
| Enterprise Value | 2.56B |
Shandong Polymer Biochemicals Co., Ltd. currently has 612.00M shares outstanding.
| Shares Outstanding | 612.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Shandong Polymer Biochemicals Co., Ltd. trades at a trailing price-to-earnings ratio of 45.54. The price-to-sales ratio is 5.01, and the price-to-book ratio stands at 4.22.
| PE Ratio | 45.54 |
| PS Ratio | 5.01 |
| PB Ratio | 4.22 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | 218.06 |
| P/OCF Ratio | N/A |
On an enterprise value basis, Shandong Polymer Biochemicals Co., Ltd. trades at an EV/EBITDA multiple of 78.78 and an EV/FCF ratio of 172.28. The EV/Sales ratio of 4.31 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 78.78 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.31 |
| EV / EBITDA | 78.78 |
| EV / EBIT | 78.78 |
| EV / FCF | 172.28 |
Shandong Polymer Biochemicals Co., Ltd. maintains a current ratio of 7.52, meaning it holds 7.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.24, indicating elevated leverage, while an interest coverage ratio of 24.09 demonstrates strong ability to service its debt obligations.
| Current Ratio | 7.52 |
| Quick Ratio | 3.77 |
| Debt / Equity | 4.24 |
| Debt / EBITDA | 1.22 |
| Interest Coverage | 24.09 |
Shandong Polymer Biochemicals Co., Ltd. posts a return on equity of 9.67 and a return on invested capital of 3.16.
| Return on Equity (ROE) | 9.67 |
| Return on Assets (ROA) | 6.47 |
| Return on Invested Capital (ROIC) | 3.16 |
| Return on Capital Employed (ROCE) | 9.46 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.83 |
Over the trailing twelve months, Shandong Polymer Biochemicals Co., Ltd. has paid 6.77M in income taxes, reflecting an effective tax rate of 9.39.
| Income Tax | 6.77M |
| Effective Tax Rate | 9.39 |
Shandong Polymer Biochemicals Co., Ltd.'s stock has gained approximately 20.58824% over the past 52 weeks. The 50-day moving average sits at 5.80, while the 200-day moving average is 6.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | 20.58824% |
| 50-Day Moving Average | 5.80 |
| 200-Day Moving Average | 6.11 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Shandong Polymer Biochemicals Co., Ltd. generated 594.15M in revenue and converted that into 65.33M in net income, yielding earnings per share of 0.11. EBITDA reached 32.51M, while operating income came in at 32.51M.
| Revenue | 594.15M |
| Gross Profit | 109.82M |
| Operating Income | 32.51M |
| Pretax Income | 72.10M |
| Net Income | 65.33M |
| EBITDA | 32.51M |
| EBIT | 32.51M |
| Earnings Per Share (EPS) | 0.11 |
Shandong Polymer Biochemicals Co., Ltd. holds 453.63M in cash and equivalents against 39.79M in total debt, resulting in a net debt position of -414.18M. Total book value stands at 704.95M, with working capital of 783.73M providing operational flexibility.
| Cash & Cash Equivalents | 453.63M |
| Total Debt | 39.79M |
| Net Debt | -414.18M |
| Equity (Book Value) | 704.95M |
| Book Value Per Share | 1.15 |
| Working Capital | 783.73M |
After subtracting -13.64M in capital expenditures, free cash flow totaled -13.64M - equivalent to -0.02 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -13.64M |
| Free Cash Flow | -13.64M |
| FCF Per Share | -0.02 |
Shandong Polymer Biochemicals Co., Ltd. operates with a gross margin of 18.48, reflecting its pricing power and cost economics. The operating margin of 5.47 and net profit margin of 11.00 provide insight into operational efficiency.
| Gross Margin | 18.48 |
| Operating Margin | 5.47 |
| Pretax Margin | 12.13 |
| Profit Margin | 11.00 |
| EBITDA Margin | 5.47 |
The company's payout ratio of 11.40 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | 11.40 |
| Shareholder Yield | -0.52 |
| FCF Yield | 0.46 |
Shandong Polymer Biochemicals Co., Ltd.'s most recent stock split took place on May 27, 2013 with a 2:3 split ratio.
| Last Split Date | 5/27/2013 |
| Split Ratio | 2:3 |
Shandong Polymer Biochemicals Co., Ltd. posts an Altman Z-Score of 16.40, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.40 |